Aktar Ali, Ph.D.

Assistant Professor

Department: Internal Medicine

Biography

EDUCATION:

 1992 Chittagong University, Bangladesh BSc (Hons) Chemistry

1994 Chittagong University, Bangladesh MSc Inorganic Chemistry

1999 Niigata University of Pharmacy, Japan PhD Pharmaceutical Science

 

POSTDOCTORAL TRAINING:

1999-2000 Niigata University of Pharmacy, Japan.

2000-2005 New York University (NYU) School of Medicine, New York.

 

AWARDS AND HONORS:

1995-1997 Student fellowship of AIEJ (Association of International Education in Japan)

1997-1999 Student fellowship of Niigata University of Pharmacy

 

PROFESSIONAL ASSOCIATIONS/AFFILIATIONS:

American Association for Cancer Research

Society for Free Radical Biology and Medicine

 

Education

Graduate School "niigata University of Pharmacy, Niigata, Japan" (), Pharmaceutical Science
Graduate School "chittagong University, Chittagong, Bangladesh" (), Chemistry

Research Interests

  • Angiogenesis
  • Cyclooxygenase 2
  • GBM invasion
  • Hypoxia and and hypoxia inducible factor

Publications

Featured Publications Legend

Featured Publications

SNS-032 prevents tumor cell induced angiogenesis by inhibition vascular endothelial growth factor.

Ali MA, Choy H, Habib AA and Saha D. Neoplasia May 2007 9 370-381

Hypoxia-Inducible Factor 1 and VEGF upregulate CXCR4 in Glioblastoma: Implication for Angiogenesis.

Zagzag D, Lan L, Ali MA, Schnee T, Lukyanov E, Yee H, Newcomb EW. Laboratory Investigation December 2006 86 1221-1232

Noscapine inhibits hypoxia mediated HIF-1a expression and angiogenesis in vitro.

Newcomb EW, Lukyanov E, Schnee T, Ali MA Lan L and Zagzag D International Journal of Oncology May 2006 28 1121-1130

The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells

Mukhopadhyay P, Ali MA, Nandi A, Carreon P, Choy H and Saha D Cancer Research February 2006 66 1758-1766

Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1 expression in human glioma cells by a proteasome-independent pathway: Implications for in vivo therapy

Newcomb EW, Ali MA, Schnee T, Lan L, Lukyanov Y, Fowkes M, Miller DC, Zagzag D Neuro Oncology July 2005 7 225-235

Results 1-10 of 10
  • 1